HealthThe most alarming thing about gray-market peptides is how little is known
Reliable data on gray-market peptide use and safety is scarce. The article focuses on BPC-157, an unapproved substance studied mostly in animals that has drawn growing attention. A preprint study, which has not undergone peer review, attempted to track its use through anonymized electronic health records.
TThe Verge★★☆☆☆2026-10-07 17:00Original
The most alarming thing about gray-market peptides is how little is known
Health